Found: 68
Select item for more details and to access through your institution.
A Comparison of the pharmacokinetics of the anticancer MET inhibitor foretinib free base tablet formulation to bisphosphate salt capsule formulation in patients with solid tumors.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 1, p. 327, doi. 10.1007/s10637-010-9536-x
- By:
- Publication type:
- Article
Gender-Related Differences in Xenobiotic Metabolism.
- Published in:
- 1991
- By:
- Publication type:
- Other
Effect of correlation on covariate selection in linear and nonlinear mixed effect models.
- Published in:
- Pharmaceutical Statistics, 2017, v. 16, n. 1, p. 45, doi. 10.1002/pst.1776
- By:
- Publication type:
- Article
Effect of assay measurement error on parameter estimation in concentration-QTc interval modeling.
- Published in:
- Pharmaceutical Statistics, 2013, v. 12, n. 3, p. 156, doi. 10.1002/pst.1567
- By:
- Publication type:
- Article
Correction: Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Pharmacokinetics and Immunogenicity of ASP0113 in CMV‐Seronegative Dialysis Patients and CMV‐Seronegative and ‐Seropositive Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 4, p. 444, doi. 10.1002/cpdd.792
- By:
- Publication type:
- Article
Correction: Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Uptake and biodisposition of 2-ylcyanamide-1,3,4-thiadiazole (LY217896) by red blood cells.
- Published in:
- Biopharmaceutics & Drug Disposition, 1995, v. 16, n. 2, p. 151, doi. 10.1002/bdd.2510160209
- By:
- Publication type:
- Article
Clinical Pharmacology of the Antibody–Drug Conjugate Enfortumab Vedotin in Advanced Urothelial Carcinoma and Other Malignant Solid Tumors.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 4, p. 423, doi. 10.1007/s40262-024-01369-0
- By:
- Publication type:
- Article
Pharmacokinetics.
- Published in:
- WIREs: Computational Statistics, 2011, v. 3, n. 4, p. 332, doi. 10.1002/wics.153
- By:
- Publication type:
- Article
Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer.
- Published in:
- PLoS ONE, 2013, v. 8, n. 3, p. 1, doi. 10.1371/journal.pone.0054014
- By:
- Publication type:
- Article
ACCP Position Statement on Hydration and Vitamin Infusion Clinics.
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 1, p. 10, doi. 10.1002/jcph.2364
- By:
- Publication type:
- Article
Thoughts on plagiarism and the case against Claudine Gay.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Correction to: Training the next generation of pharmacometric modelers: a multisector perspective.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Training the next generation of pharmacometric modelers: a multisector perspective.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Physiologically-based pharmacokinetic modeling to predict drug-drug interaction of enzalutamide with combined P-gp and CYP3A substrates.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2023, v. 50, n. 5, p. 365, doi. 10.1007/s10928-023-09867-7
- By:
- Publication type:
- Article
Pharmacokinetic comparability between two populations using nonlinear mixed effect models: a Monte Carlo study.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2023, v. 50, n. 3, p. 189, doi. 10.1007/s10928-023-09842-2
- By:
- Publication type:
- Article
A comprehensive regulatory and industry review of modeling and simulation practices in oncology clinical drug development.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2023, v. 50, n. 3, p. 147, doi. 10.1007/s10928-023-09850-2
- By:
- Publication type:
- Article
The role of quantitative systems pharmacology in pharmacometrics and the scope of the journal.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2023, v. 50, n. 1, p. 1, doi. 10.1007/s10928-023-09844-0
- By:
- Publication type:
- Article
Changes in Associate Editors at the Journal of Pharmacokinetics and Pharmacodynamics.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2023, v. 50, n. 1, p. 3, doi. 10.1007/s10928-023-09843-1
- By:
- Publication type:
- Article
Two heads are better than one: current landscape of integrating QSP and machine learning: An ISoP QSP SIG white paper by the working group on the integration of quantitative systems pharmacology and machine learning.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2022, v. 49, n. 1, p. 5, doi. 10.1007/s10928-022-09805-z
- By:
- Publication type:
- Article
Editor's note on the themed issue: integration of machine learning and quantitative systems pharmacology.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Correction to: QTc interval analysis—an ever-evolving endeavor.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
QTc interval analysis—an ever-evolving endeavor.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
The application of extreme value theory to pharmacometrics.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2021, v. 48, n. 1, p. 83, doi. 10.1007/s10928-020-09721-0
- By:
- Publication type:
- Article
A pharmacometrician's role in enhancing medication use in pregnancy and lactation.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2020, v. 47, n. 4, p. 267, doi. 10.1007/s10928-020-09707-y
- By:
- Publication type:
- Article
Musings on the current state of COVID-19 modeling and reporting.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
COVID-19: opportunity arises from a world health crisis.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
On the shoulders of giants...
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Editorial to the themed issue on application of pharmacometrics to the development of drugs for rare diseases.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2019, v. 46, n. 5, p. 385, doi. 10.1007/s10928-019-09656-1
- By:
- Publication type:
- Article
Extrapolation of praziquantel pharmacokinetics to a pediatric population: a cautionary tale.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2018, v. 45, n. 5, p. 747, doi. 10.1007/s10928-018-9601-1
- By:
- Publication type:
- Article
Editorial to themed issue: Recent advances in cardiovascular pharmacokinetic-pharmacodynamic modeling and simulation.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Correction to: Scientific white paper on concentration-QTc modeling.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Scientific white paper on concentration-QTc modeling.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2018, v. 45, n. 3, p. 383, doi. 10.1007/s10928-017-9558-5
- By:
- Publication type:
- Article
Estimation of QT interval prolongation through model-averaging.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2017, v. 44, n. 4, p. 335, doi. 10.1007/s10928-017-9523-3
- By:
- Publication type:
- Article
Editorial to the themed issue on focus on infectious disease.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
Methods and strategies for assessing uncontrolled drug-drug interactions in population pharmacokinetic analyses: results from the International Society of Pharmacometrics (ISOP) Working Group.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2016, v. 43, n. 2, p. 123, doi. 10.1007/s10928-016-9464-2
- By:
- Publication type:
- Article
Simulation studies on the estimation of total area under the curve in the presence of right-tailed censoring.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2015, v. 42, n. 1, p. 19, doi. 10.1007/s10928-014-9395-8
- By:
- Publication type:
- Article
Editorial to the Themed Issue on Translational Modeling in Neuroscience.
- Published in:
- 2013
- By:
- Publication type:
- Editorial
The effects of active metabolites on parameter estimation in linear mixed effect models of concentration-QT analyses.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2013, v. 40, n. 1, p. 101, doi. 10.1007/s10928-012-9292-y
- By:
- Publication type:
- Article
Population pharmacokinetics of APOMINE™: A meta-analysis in cancer patients and healthy males.
- Published in:
- British Journal of Clinical Pharmacology, 2004, v. 58, n. 2, p. 142, doi. 10.1111/j.1365-2125.2004.02111.x
- By:
- Publication type:
- Article
Effect of Censoring Due to Progressive Disease on Tumor Size Kinetic Parameter Estimates.
- Published in:
- 2013
- By:
- Publication type:
- Report
Pharmacokinetics in mice implanted with xenografted tumors after intravenous administration of tasidotin (ILX651) or its carboxylate metabolite.
- Published in:
- AAPS Journal, 2007, v. 9, n. 3, p. E378, doi. 10.1208/aapsj0903045
- By:
- Publication type:
- Article
Corrigendum: 2007 highlights of advances in the pharmaceutical sciences: An American Association of Pharmaceutical Scientists (AAPS) perspective.
- Published in:
- 2007
- By:
- Publication type:
- Correction notice
Population pharmacokinetics: A memorial tribute to Lewis Sheiner.
- Published in:
- 2005
- By:
- Publication type:
- Editorial
Recommended reading in population pharmacokinetic pharmacodynamics.
- Published in:
- AAPS Journal, 2005, v. 7, n. 2, p. E363, doi. 10.1208/aapsj070237
- By:
- Publication type:
- Article
Wet granulation fine particle ethylcellulose tablets: Effect of production variables and mathematical modeling of drug release.
- Published in:
- AAPS Journal, 2003, v. 5, n. 2, p. 48, doi. 10.1208/ps050213
- By:
- Publication type:
- Article
Population pharmacokinetics of immediate‐ and prolonged‐release tacrolimus formulations in liver, kidney and heart transplant recipients.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 8, p. 1692, doi. 10.1111/bcp.13952
- By:
- Publication type:
- Article
Modeling tumor growth kinetics after treatment with pazopanib or placebo in patients with renal cell carcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 1, p. 231, doi. 10.1007/s00280-013-2191-0
- By:
- Publication type:
- Article
Population pharmacokinetics of clofarabine and its metabolite 6-ketoclofarabine in adult and pediatric patients with cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 4, p. 875, doi. 10.1007/s00280-010-1376-z
- By:
- Publication type:
- Article